Claim Missing Document
Check
Articles

Found 3 Documents
Search

Analisa Strategi Keuangan dan Kelayakan pada Perencanaan Bisnis Laboratorium Klinik Colostat Test Kawalta Tarigan; Tantri Yanuar Rahmat Syah; Edi Hamdi; Muhammad Reza Hilmy
AKUA: Jurnal Akuntansi dan Keuangan Vol. 4 No. 3 (2025): Juli 2025
Publisher : Yayasan Pendidikan Penelitian Pengabdian Algero

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.54259/akua.v4i3.4792

Abstract

Colorectal cancer is a malignancy originating from the large intestine or the last small part of the large intestine before the anus. PT Mekogene Indonesia (PT MGI) business planning focuses on the innovation of a blood test-based colorectal cancer screening tool, ColoSTAT. ColoSTAT is indicated to be able to screen the risk of colorectal cancer in adult colorectal cancer suspects aged 40-85 years. Internal analysis identified ColoSTAT's competitive advantages based on simple but highly sensitive blood test technology, with strong clinical validation. This internal analysis also identified weaknesses in the form of dependence on foreign suppliers, the need for large costs for marketing, and the need to build trust in the domestic market. In terms of financial analysis with investment feasibility projections, PT MGI showed that with an initial investment of IDR 20 billion, ColoSTAT has the potential to generate positive NPV, high IRR, and attractive ROI. The financial report also estimates that breakeven can be achieved within three years through an aggressive market expansion strategy and optimal cost management. This business plan shows that PT MGI has a planned strategy to take advantage of the great opportunities in the medical device market, especially in early detection of colorectal cancer. ColoSTAT is expected to be an effective, convenient diagnostic solution that has a big impact on improving public health in Indonesia.
Evaluasi Kinerja Diagnostik dan Pemasaran Tes ColoSTAT Berbasis Darah untuk Deteksi Dini Kanker Kolorektal di Indonesia Munatsir Oteiba; Tantri Yanuar Rahmat Syah; Edi Hamdi; Muhammad Reza Hilmy
INSOLOGI: Jurnal Sains dan Teknologi Vol. 4 No. 4 (2025): Agustus 2025
Publisher : Yayasan Literasi Sains Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55123/insologi.v4i4.5760

Abstract

This study aims to evaluate the diagnostic performance of the blood-based ColoSTAT test as an early detection method for colorectal cancer while analyzing the marketing aspects of the product in Indonesia. The ColoSTAT test offers a non-invasive approach with ease of sampling and potentially high accuracy in detecting colorectal cancer at an early stage. The ColoSTAT test is a non-invasive method that utilizes specific biomarkers in the blood to identify the presence of colorectal cancer. This study method involves testing blood samples in populations at risk of colorectal cancer at several hospitals in Indonesia, and comparing the ColoSTAT test results with clinical diagnostic standards such as colonoscopy and biopsy. Diagnostic performance parameters analyzed include sensitivity, specificity, positive predictive value, negative predictive value, and overall accuracy of the test. The results indicate that the ColoSTAT test has competitive diagnostic performance and strong market potential if supported by an appropriate marketing strategy. The technological and marketing implications of the ColoSTAT test include increasing colorectal cancer screening coverage, reducing the burden on primary healthcare services, and increasing the effectiveness of colorectal cancer control in Indonesia.
Perencanaan Manajemen Sumber Daya Manusia pada Bisnis Plan Laboratorium Klinik Colostat Test Melni Rohana; Tantri Yanuar Rahmat Syah; Edi Hamdi; Muhammad Reza Hilmy
Sehat Rakyat: Jurnal Kesehatan Masyarakat Vol. 4 No. 3 (2025): Agustus 2025
Publisher : Yayasan Pendidikan Penelitian Pengabdian Algero

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.54259/sehatrakyat.v4i3.4905

Abstract

PT Mekogene Indonesia (PT MGI) business planning focuses on the innovation of a blood test-based colorectal cancer screening tool, ColoSTAT. ColoSTAT is indicated to be able to screen the risk of colorectal cancer in adult colorectal cancer suspects aged 40-85 years. PT MGI's external environmental analysis uses PESTEL and Porter's Five Forces. This research method uses literature studies and interviews with related parties. The analysis shows that the increasing trend in colorectal cancer rates, support for health regulations, and public awareness open up large market opportunities. However, there are challenges such as competition from conventional technology and challenges in educating the public about the importance of early detection. The strengths of this medical device market include high barriers to entry, low consumer bargaining power, and the potential for market dominance through technological innovation. PT MGI's human resource (HR) development planning includes a lean but effective organizational structure, a modern diagnostic technology training program, and a performance-based compensation system to increase productivity. The core team will consist of experts in diagnostic technology and market development.